$Virax Biolabs (VRAX.US)$ incoming dilution? LONDON, Aug. 21...
$Virax Biolabs (VRAX.US)$ incoming dilution?
LONDON, Aug. 21, 2024 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today that it has entered into a definitive agreement for the issuance and sale of an aggregate of 1,108,892 of its ordinary shares at a purchase price of $4.50 per share in a registered direct offering. The closing of the offering is expected to occur on or about August 23, 2024, subject to the satisfaction of customary closing conditions.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Zack5225 : that means?
SkinnyChick OP Zack5225 : The price will drop I think ?
In Faith We Trust Zack5225 : open price will be around $4.50
Zack5225 In Faith We Trust : come true